Kevin Corcoran has more than 28 years of experience in the life sciences industry. Prior to joining Pacific Biosciences, Mr. Corcoran served as President and CEO of Lynx Therapeutics from 2002–2004, where he was responsible for the development and commercialization of a massive parallel short-read sequencing technology: MPSS. While at Lynx, Mr. Corcoran jointly acquired with Solexa management the DNA cluster amplification technology that is now a key component of Illumina’s sequencing platforms. From 2004–2007, Mr. Corcoran served as Vice President and General Manager of Applied Biosystems’ DNA sequencing business, a global business with more than $600 million in annual sales. Mr. Corcoran joined Pacific Biosciences in 2007 as Vice President of software and informatics development, and was subsequently promoted to Senior Vice President responsible for all systems-related development for the PacBio RS II System. Currently, Mr. Corcoran is responsible for all marketing-related activities, advanced Informatics, applications development, program management, and all customer support functions. Mr. Corcoran holds a B.S. in Computer Science from California State University.